This HTML5 document contains 127 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://dx.doi.org/10.1111/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q45746984
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ מאמר מדעי artykuł naukowy научная статья 2012年學術文章 artigo científico 2012 nî lūn-bûn 2012年学术文章 wetenschappelijk artikel 2012年の論文 2012년 논문 2012年學術文章 مقالة علمية نشرت في 14 مارس 2012 tieteellinen artikkeli articol științific vědecký článek scientific article published on 14 March 2012 наукова стаття, опублікована в березні 2012 επιστημονικό άρθρο научна статия 2012年学术文章 บทความทางวิทยาศาสตร์ artikel ilmiah wissenschaftlicher Artikel 2012年学术文章 scientific article published on 14 March 2012 artikulong pang-agham 2012年学术文章 artículo científico publicado en 2012 2012年学术文章 ১৪ মার্চ ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ videnskabelig artikel vitskapeleg artikkel научни чланак teaduslik artikkel article scientific vetenskaplig artikel article scientifique 2012年學術文章 scientific article published on 14 March 2012 artigo científico article científic tudományos cikk 2012年学术文章 bilimsel makale scienca artikolo სამეცნიერო სტატია bài báo khoa học naučni članak artículu científicu 2012年學術文章 научни чланак vitenskapelig artikkel artikull shkencor articolo scientifico vedecký článok 2012年學術文章 artigo científico
p:P577
wds:Q45746984-05CEB7A9-0AC5-429D-BD05-0C00D072E5B9
wdt:P577
2012-03-14T00:00:00Z
p:P2860
wds:Q45746984-F276789B-ED58-4C3D-A342-DB0F66D8BD6C wds:Q45746984-F721E7F6-4605-4DFB-9E76-698F2EB675F5 wds:Q45746984-E70AF29B-7608-4D02-A814-759DDEF90C5B wds:Q45746984-13E787CD-CFBB-426E-BB67-6E2E71B02252 wds:Q45746984-20F00249-3B90-4787-A5B8-90D75AB80336 wds:Q45746984-8B21A428-8671-4F4B-9F1C-066EAFBE7372 wds:Q45746984-8D759E9B-FB1F-4087-8D65-3F151390D23C wds:Q45746984-78C57C92-ABAD-4BAD-B6EF-5A6415C99306 wds:Q45746984-79D29EF1-2B5E-4AA2-BE4F-9BF1928580FA
wdt:P2860
wd:Q57180117 wd:Q34481365 wd:Q46809390 wd:Q34664004 wd:Q36331864 wd:Q44108848 wd:Q44799933 wd:Q43238337 wd:Q46581799
p:P2093
wds:Q45746984-BD4E2A92-5F86-48B4-8D5A-57FB8AB03187 wds:Q45746984-98466973-A816-465B-84D7-9173920D72F3 wds:Q45746984-44E87FBE-0099-4B88-8F18-03897A275963 wds:Q45746984-3DCDE494-A094-474D-9C52-06EF006C868C wds:Q45746984-7ACC0342-D138-4E85-9307-5F6FAAA0083C wds:Q45746984-6DB69F82-68A9-4856-9F4C-E170390FCFD5 wds:Q45746984-050E2A52-60E6-4E7D-9F46-68F72E70A75C wds:Q45746984-E851B8C8-9F23-42F0-9B1D-687931CA50B6 wds:Q45746984-DDA7282A-15E4-4396-89C0-E3232EF72D45 wds:Q45746984-EA7BFE1A-D88F-43B6-93FD-01E42D7EA28D wds:Q45746984-8B3F4F05-8DC7-4225-8634-39728778144E
wdt:P2093
S Hodder J Gathe K Arasteh W Short P Kumar J Gold S Vanveggel K Boven J De Wet H Crauwels L Mohapi
rdfs:label
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE. Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE.
skos:prefLabel
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE. Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE.
schema:name
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE. Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE.
p:P1476
wds:Q45746984-C2235D73-EBF9-4F02-8CE3-77614DA64657
wdt:P1476
Effect of gender and race on the week 48 findings in treatment-naïve, HIV-1-infected patients enrolled in the randomized, phase III trials ECHO and THRIVE.
p:P304
wds:Q45746984-6C533EB6-FD93-47A1-8968-27B3248F9AD9
wdt:P304
406-415
p:P31
wds:Q45746984-FB239E7F-904B-4AF9-89ED-A9B4075F6F26
wdt:P31
wd:Q13442814
p:P921
wds:Q45746984-314B8838-2B8D-4EB0-95D4-9AAC098D65E9
wdt:P921
wd:Q42824827
p:P698
wds:Q45746984-9032DBDB-DE15-46BC-9501-2DFCAA3BD7E7
wdtn:P698
n10:22416849
wdt:P698
22416849
p:P1433
wds:Q45746984-CF4854FB-F752-4655-BD36-ACEDCF240F45
wdt:P1433
wd:Q15756376
p:P433
wds:Q45746984-0F7DBD55-9ED5-4E51-984B-51262420554B
p:P478
wds:Q45746984-3089F4D1-094F-4D1D-8527-4F4092D0C63B
wdt:P433
7
wdt:P478
13
p:P356
wds:Q45746984-AB07A5A5-03E2-4877-9F84-CB9A7E958969
wdtn:P356
n11:J.1468-1293.2012.00991.X
wdt:P356
10.1111/J.1468-1293.2012.00991.X